OTC Act of 2023

Bill 118 hr 4626, also known as the Over-the-Counter (OTC) Act of 2023, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to streamline the process for over-the-counter medications to be approved and brought to market.

The OTC Act of 2023 aims to modernize the regulatory framework for over-the-counter drugs by allowing the Food and Drug Administration (FDA) to rely on established safety and efficacy data when evaluating new OTC products. This would help to expedite the approval process and make it easier for consumers to access a wider range of safe and effective over-the-counter medications.

Additionally, the bill includes provisions to enhance transparency and communication between the FDA and manufacturers of OTC drugs. This would help to ensure that consumers have access to accurate information about the safety and effectiveness of the products they are using. Overall, the OTC Act of 2023 is designed to promote innovation in the over-the-counter drug market while also protecting the health and safety of consumers. It represents a bipartisan effort to modernize the regulatory framework for OTC medications and improve access to safe and effective treatments for common health conditions.